Trending News Today: FDA Says AcelRx Opioid No Better Than Current Therapies

FDA staff reviewers determined that AcelRx Pharmaceutical’s opioid painkiller offers no apparent advantage to currently available therapies, Reuters reported. According to the article, Dsuvia is a new formulation that is meant to be taken orally through a pre-filled, single-dose applicator. However, the FDA staff indicated that the small size of the pills could make it easier for patients to misplace them, potentially resulting in accidental use by others, the article reported. According to Reuters, an advisory panel to the FDA will vote on the drug on Friday.
 
A recent study found that US health insurance plans vary widely in coverage of non-drug therapies for chronic pain, Reuters reported. According to the article, the study authors found that insurers often provide little or no coverage for evidence-backed interventions for chronic pain, such as acupuncture or psychological counseling. Although certain types of non-drug therapies were covered by most policies, some insurers had expensive co-pays, the article reported. The authors noted that private and public insurers are missing important opportunities to promote alternatives to opioids.
 
A new study found that more than half of individuals with HIV who were incarcerated discontinue treatment within 3 years of leaving prison, NPR reported. According to the article, only 67.2% of the 1094 study participants remained in care 1 year after leaving prison and only 42.5% were still in care by the end of the third year. The study also showed that fully controlled HIV was more common in individuals who remained outside of prison compared with those who were reincarcerated, the article reported.



Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 


Most Popular

Related Articles

Top news of the day across the health care landscape.
Top news of the day across the health care landscape.
Top news of the day across the health care landscape
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$